ABOUT
​Quality Medication Use in Rare Disease
Through PQA Convenes: Quality Medication Use in Rare Disease, PQA will bring its members and the rare disease community together to explore quality in medication use. This one-day event will take place on Thursday, November 7, 2024, at the Renaissance Arlington Capital View hotel in Arlington, Va., prior to the PQA Leadership Summit.
​
There is a broad range of largely internal quality indicators used by health care organizations to evaluate rare disease care today. They represent the many opportunities to improve quality, but there is enormous variation in rare disease and its treatment – and many perspectives on what constitutes quality and how to improve it. As a result, establishing a consensus on what constitutes high-quality rare disease medication use is paramount.
PQA Convenes: Quality Medication Use in Rare Disease is an opportunity to:
-
highlight the importance of quality in rare disease medication use,
-
discuss the barriers to medication access,
-
focus on the care that surrounds a rare disease medication prescription and positions patients for the best outcomes possible,
-
build a foundation for consensus on quality issues among patients and the diverse payers, providers, clinicians and others who care for them, and
-
identify opportunities for research or other projects that could advance quality improvement of rare disease medication use.
Through expert presentations and interactive panel discussions, PQA will provide a platform for the perspectives of:
-
Patients, caregivers and patient advocates
-
Specialty pharmacy
-
Pharmaceutical industry organizations
-
Public and private payers
​
Learn more about PQA Convenes and why PQA is focused on rare disease.​
SCHEDULE
Thursday, November 7
7:00 a.m. - 8:00 a.m. – Breakfast
​
8:00 a.m. - 8:30 a.m. – Welcome and Overview
​​
​​
8:30 a.m. - 9:30 a.m. – Patient, Caregiver and Patient Advocate Perspectives
-
Medication access and affordability
-
Medical and social support and care satisfaction
-
Health-related quality of life and outcomes important to patients
​​​​
Ami Gopalan, PharmD, MBA, FAMCP
Senior Vice President, Head of Clinical and Editorial Services Market Access
Precision AQ
Emily Eastman
Associate Director - Centralized Specialty Pharmacy Services
University of Kentucky, Specialty Pharmacy and Infusion Services
MODERATOR
​​9:45 a.m. - 10:45 a.m. – Specialty Pharmacy and Provider Perspectives
-
Identifying and addressing access barriers
-
Education and support for adherence and persistence
-
Patient engagement, monitoring and care coordination
​
​​
​​
​11:00 a.m. - 12:00 p.m. – Biopharmaceutical Industry Perspectives ​
-
Patient support programs
-
Optimizing distribution and mitigating medications shortages
-
Registries and the power of data
​​​
​​
​12:00 p.m. - 12:45 p.m. – Lunch
​
12:45 p.m. - 1:45 p.m. – Payer and Policy Perspectives
-
Access, affordability and equity
-
Patient-centered and team-based care approaches
-
Outcomes data, real-world evidence and value-based arrangements
​
​​
​​
​
​
1:45 p.m. - 2:00 p.m. – Closing ​
​​
REGISTRATION
​PQA Convenes: Quality Medication Use in Rare Disease has a nominal registration fee. Early registration ends October 11, 2024.
​​
Please direct any questions about the PQA Convenes to Meetings@PQAalliance.org. If you experience any issues, please contact Registration@PQAalliance.org.
Cancellation Policy
All cancellation requests must be e-mailed to Registration@PQAalliance.org by October 18, 2024, to receive a refund. All cancellations are subject to a $50.00 administrative fee. Refunds will not be issued for cancellations received after October 18, 2024, but you may switch the registration until October 25, 2024. No changes are allowed after October 25, 2024. Please allow 30 business days after cancellation for refund processing.
HOTEL AND TRAVEL
PQA has secured a block of guest rooms at a special daily rate of $259 plus applicable state and local taxes at the:
​
Renaissance Arlington Capital View Hotel
2800 South Potomac Ave.
Arlington, VA, 22202
PQA's discounted guest rooms are limited; the reservation deadline is Tuesday, October 8, 2024, based on availability.
-
Hotel Cancellation Policy: Individual reservations must be canceled at least 72 hours in advance to avoid a one-night penalty.
-
Hotel Early Departure Policy: Upon early departure, an early departure of one night's room and applicable tax applies.
For assistance in booking a room, please contact Meetings@PQAalliance.org.
​
Airport Information
-
Reagan National Airport (DCA) is approximately 10 minutes from the Renaissance Arlington Capital View Hotel. Taxi fare is estimated to be $15.
-
Dulles Airport (IAD) is approximately 45 minutes from the Renaissance Arlington Capital View Hotel. Taxi fare is estimated to be $70.
​​
Complimentary Shuttle to DCA and Crystal City Metro
Ronald Reagan Washington National Airport (DCA) Shuttle:
The airport shuttle operates every 30 minutes; the first shuttle departs the hotel at 5:05 a.m. daily and with the last shuttle departing the hotel at 11:05 p.m.
The Airport shuttle picks up at:
-
Terminal A ,near Southwest, Air Canada, and Frontier
-
Terminal B, and Door 4 and between Door 6 & 7
​
The Metro shuttle to Crystal City Metro:
The Metro shuttle operates every 30 minutes; the first Metro shuttle departs the hotel at 6:30 a.m. daily with the last Metro shuttle departing the hotel at 10:00 p.m.
Parking
On-Site Parking is $44 for daily parking and $23 for hourly. Valet parking is available for $49 daily.
SPONSORSHIP OPPORTUNITIES
PQA is a premier marketplace for innovation and solutions for influencers and decision makers across sectors in medication use quality. Through PQA, sponsors will engage health care executives from pharmacies, health plans, health care providers, pharmacy benefit managers, biopharmaceutical companies, technology vendors, government agencies, research and more.
​
To explore sponsorship opportunities or develop custom sponsorship packages, contact Loren Kirk.
SPONSORS
Supporter